Loading organizations...
Rx.Health develops an enterprise-wide digital health platform that enables healthcare providers to prescribe and monitor evidence-based digital therapeutics and formulary. The company's core offering, the RxUniverse platform, integrates directly into electronic medical record systems, streamlining the delivery and management of digital medicine. This system facilitates data collection and patient interaction, enhancing the clinical workflow for various healthcare settings.
The company was founded in 2016 by Ed Berde and Ashish Atreja, emerging as a spin-off from the Mount Sinai Health System. Their initial insight stemmed from the need for a structured and scalable way to deliver digital interventions, recognizing the potential of technology to extend care beyond traditional clinical encounters. This foundation allowed them to focus on building a robust platform within the healthcare ecosystem.
Rx.Health serves healthcare organizations by enhancing patient engagement and optimizing clinical operations through its innovative software solutions. The platform aims to provide a comprehensive system for managing digital prescriptions, ensuring seamless integration into existing healthcare infrastructures. The company envisions a future where digital medicine is a standard component of patient care, contributing to improved health outcomes and more efficient healthcare delivery.
Rx.Health has raised $2.0M across 1 funding round.
Rx.Health has raised $2.0M in total across 1 funding round.
Rx.Health has raised $2.0M in total across 1 funding round.
Rx.Health's investors include 1984 Ventures, Alchemist Accelerator, Benchmark, Calm/Storm Ventures, GSR Ventures, Incisive Ventures, Plug & Play Ventures, Surface Ventures, Tenaya Capital, Niels Gron.
Rx.Health is a technology company that builds a cloud-based, HIPAA-compliant digital medicine platform aggregating evidence-based digital therapeutics, apps, ePROs, surveys, health education, telehealth, secure messaging, and wearables into automated, physician-directed digital navigation pathways (DNPs) for disease- or procedure-specific care.[1] It serves healthcare providers, payers, life sciences organizations, and health systems like Yale New Haven Health and UnitedHealthcare, solving problems like patient no-shows, readmissions, care coordination inefficiencies, and fragmented digital health delivery by streamlining end-to-end patient journeys with AI analytics, automated nudges, and monitoring—driving outcomes such as 85% no-show reductions and revenue boosts from preventive care.[1][2][4] Founded in 2016 in New York and acquired by Commure in October 2023 after raising $1.75M, Rx.Health supports 6 million patient encounters annually, 55 million messages, and 100 million API interactions monthly via scalable infrastructure.[1][2]
Rx.Health emerged from Mount Sinai Health System, leveraging its clinical expertise to create the RxUniverse platform—the first enterprise-level digital medicine delivery system integrated directly into electronic medical records (EMRs) for faster innovation in patient care.[1][3] Founded in 2016 in New York, New York, the company quickly gained traction with leading U.S. health organizations, pioneering automated care pathways that unify disparate digital tools.[1] Key early milestones include partnerships with Yale New Haven Health for expanded scalability and adoption by UnitedHealthcare, culminating in its acquisition by Commure in October 2023, which integrated it into a broader product portfolio to accelerate nationwide health assurance.[1][2]
Rx.Health rides the digital therapeutics and AI-driven care coordination trend, capitalizing on post-pandemic shifts toward automated, personalized patient engagement amid rising healthcare costs and chronic disease burdens.[1][2] Its timing aligns with EMR adoption surges and payer demands for value-based care, where fragmented apps fail; by unifying tools into scalable DNPs, it counters market forces like no-show rates (20-30% industry average) and readmission penalties, influencing the ecosystem through integrations with Azure, Twilio, and EMRs that enable health systems to deliver "health assurance" at scale.[1][2][4] As part of Commure, it amplifies impact by embedding digital medicine into enterprise workflows, setting standards for AI-augmented pathways that 500+ organizations now customize.[1]
Rx.Health's acquisition positions it for hypergrowth within Commure, expanding its 500+ DNPs and Azure-fueled infrastructure to more global health networks amid AI health tech's projected $200B+ market by 2030. Trends like multimodal AI analytics, wearable proliferation, and regulatory tailwinds for digital therapeutics will propel deeper EMR integrations and predictive care, evolving its role from coordinator to proactive health orchestrator—ultimately redefining scalable, physician-led digital medicine from its Mount Sinai roots.[1][2]
Rx.Health has raised $2.0M across 1 funding round. Most recently, it raised $2.0M Seed in September 2018.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Sep 1, 2018 | $2.0M Seed | 1984 Ventures, Alchemist Accelerator, Benchmark, Calm/Storm Ventures, GSR Ventures, Incisive Ventures, Plug & Play Ventures, Surface Ventures, Tenaya Capital, Niels Gron |